| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium ion binding | 2.52e-06 | 14 | 145 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.52e-05 | 26 | 145 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 3.52e-05 | 26 | 145 | 4 | GO:0031420 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 4.93e-06 | 17 | 145 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 4.61e-05 | 29 | 145 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | external encapsulating structure | NPHS1 CD248 LAMB3 LINGO3 PKHD1L1 LRIG3 CLEC14A VWA5A NCAN ZP4 MMP19 AGRN OTOG IMPG2 | 2.00e-04 | 658 | 145 | 14 | GO:0030312 |
| HumanPheno | Photosensitive myoclonic seizure | 3.50e-05 | 8 | 45 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 3.50e-05 | 8 | 45 | 3 | HP:0200048 | |
| Domain | Na_trans_cytopl | 4.48e-08 | 6 | 140 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 4.48e-08 | 6 | 140 | 4 | IPR024583 | |
| Domain | Na_channel_asu | 6.13e-07 | 10 | 140 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 6.13e-07 | 10 | 140 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 6.13e-07 | 10 | 140 | 4 | PF06512 | |
| Domain | EGF_3 | CD248 ADAM12 CELSR1 CELSR3 CLEC14A NCAN LRP4 ASTN2 AGRN OTOG IMPG2 | 1.62e-06 | 235 | 140 | 11 | PS50026 |
| Domain | EGF_1 | CD248 LAMB3 ADAM12 CELSR1 CELSR3 CLEC14A NCAN LRP4 ASTN2 AGRN IMPG2 | 3.56e-06 | 255 | 140 | 11 | PS00022 |
| Domain | EGF_2 | CD248 LAMB3 ADAM12 CELSR1 CELSR3 CLEC14A NCAN LRP4 ASTN2 AGRN IMPG2 | 5.14e-06 | 265 | 140 | 11 | PS01186 |
| Domain | EGF-like_dom | CD248 ADAM12 CELSR1 CELSR3 CLEC14A NCAN LRP4 AGRN OTOG IMPG2 | 1.86e-05 | 249 | 140 | 10 | IPR000742 |
| Domain | EGF-like_CS | CD248 LAMB3 ADAM12 CELSR1 CELSR3 CLEC14A NCAN LRP4 AGRN IMPG2 | 2.79e-05 | 261 | 140 | 10 | IPR013032 |
| Domain | IQ | 3.26e-05 | 81 | 140 | 6 | SM00015 | |
| Domain | HRM | 5.38e-05 | 28 | 140 | 4 | PF02793 | |
| Domain | IQ_motif_EF-hand-BS | 5.92e-05 | 90 | 140 | 6 | IPR000048 | |
| Domain | GAIN_dom_N | 6.51e-05 | 11 | 140 | 3 | IPR032471 | |
| Domain | GAIN | 6.51e-05 | 11 | 140 | 3 | PF16489 | |
| Domain | IQ | 7.11e-05 | 93 | 140 | 6 | PS50096 | |
| Domain | EGF_LAM_2 | 7.12e-05 | 30 | 140 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 7.12e-05 | 30 | 140 | 4 | PS01248 | |
| Domain | Ig_I-set | 9.41e-05 | 190 | 140 | 8 | IPR013098 | |
| Domain | I-set | 9.41e-05 | 190 | 140 | 8 | PF07679 | |
| Domain | GPS | 1.18e-04 | 34 | 140 | 4 | SM00303 | |
| Domain | EGF_Lam | 1.32e-04 | 35 | 140 | 4 | SM00180 | |
| Domain | GPS | 1.32e-04 | 35 | 140 | 4 | PF01825 | |
| Domain | Laminin_EGF | 1.32e-04 | 35 | 140 | 4 | PF00053 | |
| Domain | SEA | 1.41e-04 | 14 | 140 | 3 | SM00200 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.47e-04 | 106 | 140 | 6 | IPR000152 | |
| Domain | GPS | 1.48e-04 | 36 | 140 | 4 | PS50221 | |
| Domain | GPS | 1.65e-04 | 37 | 140 | 4 | IPR000203 | |
| Domain | GYF | 1.67e-04 | 3 | 140 | 2 | PS50829 | |
| Domain | GYF | 1.67e-04 | 3 | 140 | 2 | SM00444 | |
| Domain | GYF | 1.67e-04 | 3 | 140 | 2 | PF02213 | |
| Domain | - | 1.67e-04 | 3 | 140 | 2 | 3.30.1490.40 | |
| Domain | - | 1.76e-04 | 15 | 140 | 3 | 3.30.70.960 | |
| Domain | Laminin_EGF | 1.83e-04 | 38 | 140 | 4 | IPR002049 | |
| Domain | GPCR_2_extracellular_dom | 2.24e-04 | 40 | 140 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 2.24e-04 | 40 | 140 | 4 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 2.24e-04 | 40 | 140 | 4 | PS50227 | |
| Domain | EGF_CA | 3.16e-04 | 122 | 140 | 6 | SM00179 | |
| Domain | P5-ATPase | 3.31e-04 | 4 | 140 | 2 | PF12409 | |
| Domain | GYF | 3.31e-04 | 4 | 140 | 2 | IPR003169 | |
| Domain | EGF-like_Ca-bd_dom | 3.45e-04 | 124 | 140 | 6 | IPR001881 | |
| Domain | EGF | 3.76e-04 | 126 | 140 | 6 | PF00008 | |
| Domain | EGF | 4.01e-04 | 235 | 140 | 8 | SM00181 | |
| Domain | IGc2 | 4.01e-04 | 235 | 140 | 8 | SM00408 | |
| Domain | Ig_sub2 | 4.01e-04 | 235 | 140 | 8 | IPR003598 | |
| Domain | 7tm_2 | 5.33e-04 | 50 | 140 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 5.33e-04 | 50 | 140 | 4 | PS00650 | |
| Domain | Groucho_enhance | 5.50e-04 | 5 | 140 | 2 | IPR009146 | |
| Domain | TLE_N | 5.50e-04 | 5 | 140 | 2 | PF03920 | |
| Domain | P-type_TPase_V | 5.50e-04 | 5 | 140 | 2 | IPR006544 | |
| Domain | Groucho/TLE_N | 5.50e-04 | 5 | 140 | 2 | IPR005617 | |
| Domain | Tet-R_TetA/multi-R_MdtG | 5.50e-04 | 5 | 140 | 2 | IPR001958 | |
| Domain | SEA | 5.72e-04 | 22 | 140 | 3 | PF01390 | |
| Domain | SEA | 6.54e-04 | 23 | 140 | 3 | PS50024 | |
| Domain | SEA_dom | 6.54e-04 | 23 | 140 | 3 | IPR000082 | |
| Domain | HormR | 8.40e-04 | 25 | 140 | 3 | SM00008 | |
| Domain | Channel_four-helix_dom | 8.78e-04 | 57 | 140 | 4 | IPR027359 | |
| Domain | - | 8.78e-04 | 57 | 140 | 4 | 1.20.120.350 | |
| Domain | ASX_HYDROXYL | 9.37e-04 | 100 | 140 | 5 | PS00010 | |
| Domain | GPCR_2_secretin-like | 1.07e-03 | 60 | 140 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 1.07e-03 | 60 | 140 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.13e-03 | 61 | 140 | 4 | PS50261 | |
| Domain | IG | 1.29e-03 | 421 | 140 | 10 | SM00409 | |
| Domain | Ig_sub | 1.29e-03 | 421 | 140 | 10 | IPR003599 | |
| Domain | - | NPHS1 SDK2 DSCAM SPEG IGDCC3 LINGO3 PKHD1L1 LRIG3 IL1R2 NCAN ASTN2 ADGRA3 SECTM1 | 1.46e-03 | 663 | 140 | 13 | 2.60.40.10 |
| Domain | WD40_repeat_CS | 1.49e-03 | 164 | 140 | 6 | IPR019775 | |
| Domain | WD40_repeat_dom | 1.82e-03 | 297 | 140 | 8 | IPR017986 | |
| Domain | IQ | 1.99e-03 | 71 | 140 | 4 | PF00612 | |
| Domain | Ig-like_fold | NPHS1 SDK2 DSCAM SPEG IGDCC3 LINGO3 PKHD1L1 LRIG3 IL1R2 NCAN ASTN2 ADGRA3 SECTM1 | 2.53e-03 | 706 | 140 | 13 | IPR013783 |
| Domain | FN3 | 2.73e-03 | 185 | 140 | 6 | SM00060 | |
| Domain | LAM_G_DOMAIN | 2.87e-03 | 38 | 140 | 3 | PS50025 | |
| Domain | MACPF | 2.94e-03 | 11 | 140 | 2 | PF01823 | |
| Domain | ig | 3.12e-03 | 190 | 140 | 6 | PF00047 | |
| Domain | Immunoglobulin | 3.12e-03 | 190 | 140 | 6 | IPR013151 | |
| Domain | WD40 | 3.42e-03 | 259 | 140 | 7 | PF00400 | |
| Domain | MACPF | 3.51e-03 | 12 | 140 | 2 | IPR020864 | |
| Domain | MACPF | 3.51e-03 | 12 | 140 | 2 | SM00457 | |
| Domain | - | 3.67e-03 | 333 | 140 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.80e-03 | 335 | 140 | 8 | IPR015943 | |
| Domain | FN3 | 3.91e-03 | 199 | 140 | 6 | PS50853 | |
| Domain | IG_LIKE | 3.94e-03 | 491 | 140 | 10 | PS50835 | |
| Domain | WD40 | 4.13e-03 | 268 | 140 | 7 | SM00320 | |
| Domain | LamG | 4.36e-03 | 44 | 140 | 3 | SM00282 | |
| Domain | WD40_repeat | 4.47e-03 | 272 | 140 | 7 | IPR001680 | |
| Domain | Ig-like_dom | 4.66e-03 | 503 | 140 | 10 | IPR007110 | |
| Domain | Cys-rich_flank_reg_C | 4.70e-03 | 90 | 140 | 4 | IPR000483 | |
| Domain | LRRCT | 4.70e-03 | 90 | 140 | 4 | SM00082 | |
| Domain | Dynein_HC_stalk | 4.79e-03 | 14 | 140 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.79e-03 | 14 | 140 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.79e-03 | 14 | 140 | 2 | PF08393 | |
| Domain | MT | 4.79e-03 | 14 | 140 | 2 | PF12777 | |
| Domain | FN3_dom | 4.96e-03 | 209 | 140 | 6 | IPR003961 | |
| Domain | WD_REPEATS_1 | 5.03e-03 | 278 | 140 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 5.13e-03 | 279 | 140 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 5.13e-03 | 279 | 140 | 7 | PS50294 | |
| Domain | DHC_fam | 5.49e-03 | 15 | 140 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 5.49e-03 | 15 | 140 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.49e-03 | 15 | 140 | 2 | IPR004273 | |
| Domain | BAR_dom | 6.25e-03 | 16 | 140 | 2 | IPR004148 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 7.00e-05 | 31 | 102 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 7.95e-05 | 32 | 102 | 4 | M27455 | |
| Pubmed | 1.49e-09 | 5 | 146 | 4 | 8812438 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 4.44e-09 | 6 | 146 | 4 | 23652591 | |
| Pubmed | 3.69e-08 | 9 | 146 | 4 | 16382098 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 MFHAS1 SPEG LAMB3 TEP1 KIFC2 SNX30 TMEM129 FASN CELSR1 CELSR3 CANT1 NBEAL2 NAV1 LRP4 TANC1 NUP188 AGRN PRRT4 DYNC1H1 | 4.27e-08 | 1105 | 146 | 20 | 35748872 |
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 19284629 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 33895391 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 23859570 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 12610651 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 18784617 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 17544618 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 14973256 | ||
| Pubmed | 2.07e-07 | 13 | 146 | 4 | 15123669 | ||
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 17537961 | ||
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 35801810 | ||
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 35031483 | ||
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 29578003 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 2.89e-07 | 4 | 146 | 3 | 8974318 | |
| Pubmed | 7.20e-07 | 5 | 146 | 3 | 1679748 | ||
| Pubmed | 7.20e-07 | 5 | 146 | 3 | 24337656 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | LAMB3 MINPP1 ITGA7 ADAM12 PAICS SIAE CELSR1 GLA CELSR3 CANT1 MICAL2 LRP4 TMEM231 TAP1 AGRN PBXIP1 ADGRA3 PPP6R3 | 3.16e-06 | 1201 | 146 | 18 | 35696571 |
| Pubmed | PDE3B DENND4A LAMB3 FAM91A1 GIGYF1 ANKZF1 WASH6P TUBGCP3 GIGYF2 TANC1 NMT1 AGRN PBXIP1 | 3.95e-06 | 650 | 146 | 13 | 38777146 | |
| Pubmed | 5.98e-06 | 9 | 146 | 3 | 15746173 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.11e-05 | 33 | 146 | 4 | 25713288 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.36e-05 | 256 | 146 | 8 | 33397691 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.55e-05 | 12 | 146 | 3 | 30175250 | |
| Pubmed | 1.55e-05 | 12 | 146 | 3 | 8169823 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 20346423 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 1.75e-05 | 2 | 146 | 2 | 10827969 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 19694741 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 1.75e-05 | 2 | 146 | 2 | 11245985 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 9403057 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 1.75e-05 | 2 | 146 | 2 | 1317301 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 1.75e-05 | 2 | 146 | 2 | 23016767 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 27153334 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 15925480 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 1.75e-05 | 2 | 146 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 1.75e-05 | 2 | 146 | 2 | 25172946 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 31439038 | ||
| Pubmed | Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses. | 1.75e-05 | 2 | 146 | 2 | 22854782 | |
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 1.75e-05 | 2 | 146 | 2 | 15249644 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 27690330 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 25799488 | ||
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 1.75e-05 | 2 | 146 | 2 | 23965409 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 30693367 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 29649454 | ||
| Pubmed | Genetic Method for Labeling Electrically Coupled Cells: Application to Retina. | 1.75e-05 | 2 | 146 | 2 | 26778956 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 33096315 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 26311622 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 21377452 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 3.18e-05 | 15 | 146 | 3 | 9726281 | |
| Pubmed | 3.24e-05 | 43 | 146 | 4 | 36950384 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 32185219 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 32005694 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 24244707 | ||
| Pubmed | Fatty acid synthase downregulation contributes to acute lung injury in murine diet-induced obesity. | 5.24e-05 | 3 | 146 | 2 | 31287803 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 21969364 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 27816501 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 11677057 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 26297880 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 28784306 | ||
| Pubmed | Activation of G0/G1 switch gene 2 by endoplasmic reticulum stress enhances hepatic steatosis. | 5.24e-05 | 3 | 146 | 2 | 31271806 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 37681411 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 19699781 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 35430343 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 32845893 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 28518218 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 19270815 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 16052353 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 25155934 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 17928448 | ||
| Pubmed | The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers. | 5.24e-05 | 3 | 146 | 2 | 32698888 | |
| Pubmed | 5.94e-05 | 407 | 146 | 9 | 12693553 | ||
| Pubmed | 6.97e-05 | 101 | 146 | 5 | 18519826 | ||
| Pubmed | 8.53e-05 | 332 | 146 | 8 | 37433992 | ||
| Pubmed | The Xbp1s/GalE axis links ER stress to postprandial hepatic metabolism. | 1.04e-04 | 4 | 146 | 2 | 23257357 | |
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 1.04e-04 | 4 | 146 | 2 | 26637798 | |
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 8645603 | ||
| Pubmed | 4EHP and GIGYF1/2 Mediate Translation-Coupled Messenger RNA Decay. | 1.04e-04 | 4 | 146 | 2 | 33053355 | |
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 21089229 | ||
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 28671670 | ||
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 22260870 | ||
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 38297082 | ||
| Pubmed | Panel of markers can accurately predict endometriosis in a subset of patients. | 1.04e-04 | 4 | 146 | 2 | 17706208 | |
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 1.04e-04 | 4 | 146 | 2 | 37224017 | |
| Pubmed | Nestin negatively regulates postsynaptic differentiation of the neuromuscular synapse. | 1.04e-04 | 4 | 146 | 2 | 21278733 | |
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 25951715 | ||
| Pubmed | Nav1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis. | 1.04e-04 | 4 | 146 | 2 | 38172636 | |
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 21156207 | ||
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 37356721 | ||
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 31594848 | ||
| Pubmed | Expression of phosphacan and neurocan during early development of mouse retinofugal pathway. | 1.04e-04 | 4 | 146 | 2 | 15283989 | |
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 32879135 | ||
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 28992327 | ||
| Pubmed | Developmental expression profiles of Celsr (Flamingo) genes in the mouse. | 1.04e-04 | 4 | 146 | 2 | 11850187 | |
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 14508709 | ||
| Pubmed | Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. | 1.04e-04 | 4 | 146 | 2 | 29562231 | |
| Pubmed | 1.74e-04 | 5 | 146 | 2 | 1303260 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.74e-04 | 5 | 146 | 2 | 22875929 | |
| Pubmed | Expression of Epiplakin1 in the developing and adult mouse retina. | 1.74e-04 | 5 | 146 | 2 | 20151282 | |
| Pubmed | PAQR4 regulates adipocyte function and systemic metabolic health by mediating ceramide levels. | 1.74e-04 | 5 | 146 | 2 | 38961186 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 5.84e-05 | 127 | 147 | 5 | chr2q24 | |
| Cytoband | 19p13.3 | 1.22e-04 | 237 | 147 | 6 | 19p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.64e-04 | 797 | 147 | 10 | chr19p13 | |
| Cytoband | 2q24 | 5.50e-04 | 11 | 147 | 2 | 2q24 | |
| Cytoband | 2q12 | 6.58e-04 | 12 | 147 | 2 | 2q12 | |
| Cytoband | 8p23 | 9.04e-04 | 14 | 147 | 2 | 8p23 | |
| Cytoband | 11p15.1 | 9.63e-04 | 60 | 147 | 3 | 11p15.1 | |
| Cytoband | 2q24.3 | 1.19e-03 | 16 | 147 | 2 | 2q24.3 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.00e-07 | 9 | 98 | 4 | 1203 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.73e-05 | 161 | 98 | 7 | 593 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 8.69e-05 | 3 | 98 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 8.69e-05 | 3 | 98 | 2 | 1189 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 2.88e-04 | 5 | 98 | 2 | 1213 | |
| GeneFamily | WD repeat domain containing | 5.58e-04 | 262 | 98 | 7 | 362 | |
| GeneFamily | Fibronectin type III domain containing | 1.79e-03 | 160 | 98 | 5 | 555 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN | 2.03e-06 | 200 | 147 | 9 | M3875 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.55e-07 | 192 | 147 | 8 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-07 | 198 | 147 | 8 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-ELP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-06 | 170 | 147 | 7 | a50e558d0b38100ccbdccb90647fe93e85bffd86 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.00e-06 | 176 | 147 | 7 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.07e-06 | 177 | 147 | 7 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-06 | 179 | 147 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.23e-06 | 179 | 147 | 7 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-06 | 181 | 147 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 2.59e-06 | 183 | 147 | 7 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.59e-06 | 183 | 147 | 7 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 3.09e-06 | 188 | 147 | 7 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.20e-06 | 189 | 147 | 7 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-06 | 69 | 147 | 5 | 1592edde44c3927d6a2350eb00f92c10d3adf692 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.32e-06 | 190 | 147 | 7 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.43e-06 | 191 | 147 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 3.55e-06 | 192 | 147 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.55e-06 | 192 | 147 | 7 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.80e-06 | 194 | 147 | 7 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.80e-06 | 194 | 147 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.21e-06 | 197 | 147 | 7 | 49689a03ab31e53386dbe15c77c09ca3a14ebf4e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-06 | 198 | 147 | 7 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.50e-06 | 199 | 147 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.50e-06 | 199 | 147 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.50e-06 | 199 | 147 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.65e-06 | 200 | 147 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.65e-06 | 200 | 147 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.65e-06 | 200 | 147 | 7 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.65e-06 | 200 | 147 | 7 | be46efc899d06c55ee297bee3126f69bcdb2048b | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.33e-05 | 156 | 147 | 6 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.33e-05 | 156 | 147 | 6 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.59e-05 | 161 | 147 | 6 | e6e294b4ba911c1327664f1a0f93207096c6de03 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.71e-05 | 163 | 147 | 6 | edca1d1a345109dbdeb7ee5464faefab1993fdb2 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-05 | 167 | 147 | 6 | 43a9375fdbafd7450c553e4620e21537e08639dd | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 169 | 147 | 6 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 169 | 147 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.32e-05 | 172 | 147 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 173 | 147 | 6 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 173 | 147 | 6 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-05 | 177 | 147 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 2.90e-05 | 179 | 147 | 6 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.99e-05 | 180 | 147 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.08e-05 | 181 | 147 | 6 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 3.08e-05 | 181 | 147 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-05 | 182 | 147 | 6 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | 3.28e-05 | 183 | 147 | 6 | e4cbd39575b5a4612d9934532e3bad63286f8aa5 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 183 | 147 | 6 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-05 | 184 | 147 | 6 | 45ff845ceed5960a997545c1009012b65e377d50 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 3.38e-05 | 184 | 147 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-05 | 184 | 147 | 6 | 2cc2646dee3c6001f7c10b7449c17d1935021958 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 185 | 147 | 6 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.59e-05 | 186 | 147 | 6 | 37b93ebd64ebbd08193a746e5bc9b350c2570733 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-05 | 186 | 147 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-05 | 186 | 147 | 6 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-Tregs|bone_marrow / Manually curated celltypes from each tissue | 3.70e-05 | 187 | 147 | 6 | bda716a64262325e6e68b281caf131f1840fd298 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.70e-05 | 187 | 147 | 6 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 187 | 147 | 6 | fe9fc21192ede2eea61f419d20ccda254569d0a6 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.81e-05 | 188 | 147 | 6 | 8ffb5394f7b00ea483a5fe4df894d22fda935e5c | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.81e-05 | 188 | 147 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-05 | 188 | 147 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.81e-05 | 188 | 147 | 6 | 137ed9958044fab7a13648affb469585d1c48cf6 | |
| ToppCell | facs-Trachea-3m-Epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.93e-05 | 189 | 147 | 6 | f8959cc2c14899c8dfeb1b5e51e187537df2f03e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 3.93e-05 | 189 | 147 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 189 | 147 | 6 | e60a3d6aa84788c29f23439f1c747431ea581bc3 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 3.93e-05 | 189 | 147 | 6 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 4.04e-05 | 190 | 147 | 6 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | droplet-Trachea-3m-Epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.04e-05 | 190 | 147 | 6 | 0114cf48612d78c3ada4d8a05850501fef6892c5 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.04e-05 | 190 | 147 | 6 | 01e7747547ea1f3049a11a1717565ba71dd52bdc | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-05 | 190 | 147 | 6 | e647f9a2dcf7f2dffef53c45bbe171416518fd59 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.04e-05 | 190 | 147 | 6 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-05 | 190 | 147 | 6 | 434de72dde09644efbddcaa643a4a3eaf5f643bf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.16e-05 | 191 | 147 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.16e-05 | 191 | 147 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.16e-05 | 191 | 147 | 6 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | T_cells-Central_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.16e-05 | 191 | 147 | 6 | 25dd538d6a361bd3367c8a1c0dfc9e7003061af3 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.29e-05 | 192 | 147 | 6 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 4.29e-05 | 192 | 147 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 4.29e-05 | 192 | 147 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.29e-05 | 192 | 147 | 6 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.29e-05 | 192 | 147 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.41e-05 | 193 | 147 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 4.41e-05 | 193 | 147 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-05 | 193 | 147 | 6 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.41e-05 | 193 | 147 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | facs-Trachea-24m-Epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-05 | 193 | 147 | 6 | ec49a83b24371579d4ad46aad91c25115aa226f9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-05 | 193 | 147 | 6 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | facs-Lung-3m-Epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-05 | 193 | 147 | 6 | db5e43e0b571737e7006365bdf0575340b8b900b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.54e-05 | 194 | 147 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.54e-05 | 194 | 147 | 6 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.54e-05 | 194 | 147 | 6 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | facs-Tongue|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 195 | 147 | 6 | 77128895db9221a64a171082d468ebcd6380c936 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-05 | 196 | 147 | 6 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-05 | 196 | 147 | 6 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.95e-05 | 197 | 147 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.95e-05 | 197 | 147 | 6 | d2b2eaa6f7294ff56b84a69c8727c7e0f9fd0466 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.09e-05 | 198 | 147 | 6 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.09e-05 | 198 | 147 | 6 | de5748c2b66ecc432974cf095ecd241369579f7c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-05 | 199 | 147 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | medial-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-05 | 199 | 147 | 6 | 456460c761e26ed4b1d88d9bee4d2a7c9bd9d416 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-05 | 199 | 147 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-05 | 199 | 147 | 6 | 5263338242f95c04690d0795749ccc20b0d19f7a | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 9.97e-08 | 10 | 140 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 9.97e-08 | 10 | 140 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.33e-07 | 12 | 140 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.32e-06 | 22 | 140 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 8.60e-06 | 9 | 140 | 3 | C3502809 | |
| Disease | epilepsy (implicated_via_orthology) | 1.34e-05 | 163 | 140 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 2.24e-05 | 2 | 140 | 2 | C4551549 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 2.89e-05 | 13 | 140 | 3 | C0751122 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 5.60e-05 | 16 | 140 | 3 | C0751885 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 6.77e-05 | 17 | 140 | 3 | C0751883 | |
| Disease | Neurodevelopmental Disorders | 8.32e-05 | 93 | 140 | 5 | C1535926 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 9.58e-05 | 19 | 140 | 3 | C0751884 | |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 1.33e-04 | 4 | 140 | 2 | C2752089 | |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 1.33e-04 | 4 | 140 | 2 | cv:C5574675 | |
| Disease | juvenile-onset Parkinson's disease (implicated_via_orthology) | 1.33e-04 | 4 | 140 | 2 | DOID:0060893 (implicated_via_orthology) | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 1.33e-04 | 4 | 140 | 2 | cv:C2752089 | |
| Disease | Kufor-Rakeb syndrome (implicated_via_orthology) | 1.33e-04 | 4 | 140 | 2 | DOID:0060556 (implicated_via_orthology) | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 1.33e-04 | 4 | 140 | 2 | 201300 | |
| Disease | Myasthenic Syndromes, Congenital | 1.97e-04 | 24 | 140 | 3 | C0751882 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 2 | 2.21e-04 | 5 | 140 | 2 | C0020072 | |
| Disease | Cerebral Small Vessel Diseases | 2.21e-04 | 5 | 140 | 2 | C2733158 | |
| Disease | muscular disease (implicated_via_orthology) | 2.21e-04 | 5 | 140 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Sensory Neuropathy, Hereditary | 3.31e-04 | 6 | 140 | 2 | C0699739 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 3.86e-04 | 30 | 140 | 3 | DOID:332 (implicated_via_orthology) | |
| Disease | Seizure, Febrile, Simple | 4.62e-04 | 7 | 140 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 4.62e-04 | 7 | 140 | 2 | C0751057 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 4.62e-04 | 7 | 140 | 2 | C0020075 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 6.14e-04 | 8 | 140 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 6.14e-04 | 8 | 140 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 6.14e-04 | 8 | 140 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 6.14e-04 | 8 | 140 | 2 | C0751120 | |
| Disease | granule cell layer dentate gyrus volume | 6.14e-04 | 8 | 140 | 2 | EFO_0009403 | |
| Disease | Myoclonic Encephalopathy | 6.14e-04 | 8 | 140 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 6.14e-04 | 8 | 140 | 2 | C0393703 | |
| Disease | resting heart rate | 7.41e-04 | 149 | 140 | 5 | EFO_0004351 | |
| Disease | Febrile Convulsions | 7.87e-04 | 9 | 140 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 7.87e-04 | 9 | 140 | 2 | C0014550 | |
| Disease | Epilepsy, Myoclonic, Infantile | 9.81e-04 | 10 | 140 | 2 | C0917800 | |
| Disease | Proteinuria | 1.12e-03 | 43 | 140 | 3 | C0033687 | |
| Disease | nucleus accumbens volume change measurement | 1.20e-03 | 11 | 140 | 2 | EFO_0021493 | |
| Disease | Myoclonic Astatic Epilepsy | 1.20e-03 | 11 | 140 | 2 | C0393702 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.64e-03 | 49 | 140 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 1.68e-03 | 13 | 140 | 2 | C0270914 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 1.96e-03 | 14 | 140 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | MMR-related febrile seizures | 2.25e-03 | 15 | 140 | 2 | EFO_0006519 | |
| Disease | Polyposis, Adenomatous Intestinal | 2.57e-03 | 16 | 140 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 2.57e-03 | 16 | 140 | 2 | C2713443 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.57e-03 | 16 | 140 | 2 | C0393706 | |
| Disease | Adenomatous Polyposis Coli | 2.90e-03 | 17 | 140 | 2 | C0032580 | |
| Disease | MHPG measurement, 5-HIAA measurement | 2.90e-03 | 17 | 140 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.08e-03 | 206 | 140 | 5 | C0152013 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 3.25e-03 | 18 | 140 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.25e-03 | 18 | 140 | 2 | HP_0002373 | |
| Disease | diet measurement, body mass index | 4.02e-03 | 20 | 140 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | taurocholate measurement | 4.02e-03 | 20 | 140 | 2 | EFO_0010538 | |
| Disease | left atrial function | 4.42e-03 | 21 | 140 | 2 | EFO_0004294 | |
| Disease | Arthrogryposis | 4.42e-03 | 21 | 140 | 2 | C0003886 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESWLSVGPGGEITEL | 196 | Q15361 | |
| WLSSPEALDGIVGTL | 191 | Q2M3D2 | |
| WSPDGSRLLFTVLGE | 336 | Q9NRG9 | |
| SLSQGDPDAAIWLGD | 1256 | O15013 | |
| LTEDGLDLWGTVPTA | 491 | Q4VNC0 | |
| SLASVPEGLWASLGQ | 271 | P02750 | |
| LEASGSLESPVLEWS | 711 | A0A096LP49 | |
| LATLWAEPLSEEAGG | 956 | Q96Q42 | |
| GEFTVIHALTGWLPE | 261 | Q8N7X0 | |
| LGWGLPALVVATSVG | 986 | O60242 | |
| DKTGTLTRDGLDLWG | 486 | Q4VNC1 | |
| LISSIDPGAFWGLSS | 116 | Q8IWK6 | |
| DPLGSTSRWLVDTGN | 616 | Q9NXL2 | |
| AGSSEWLAVDGLVSP | 56 | P18848 | |
| DSLVGAGPASRLLWI | 71 | Q9HCU0 | |
| PFSDWGRLEAAILSG | 16 | Q9UKT5 | |
| SPLGATQLDTDGALW | 2001 | O00468 | |
| GVALVESGWGSLLPT | 406 | O96018 | |
| SVGSGDLWIPVKSFD | 46 | O43184 | |
| LVSWDIPGARALDNG | 21 | P06280 | |
| SLQDTLIWSFAGPIG | 2606 | Q9NYQ6 | |
| TGKASELERLALWPG | 3946 | Q96M86 | |
| STLLESTLEGAPEWA | 61 | Q3SXR2 | |
| TLSRVLWLSGLSEPG | 11 | Q9H5X1 | |
| STLPALRESDIGWSG | 71 | O75129 | |
| PATLQGATDSLGLEW | 1611 | Q7Z401 | |
| RTAAGSSWEDPSLLE | 361 | Q9BTD8 | |
| ALTGEGLPEALQSLW | 156 | Q969Q4 | |
| LTWRLPDVSEAGGSG | 816 | O14526 | |
| IAKTLASEWLGSPGT | 381 | Q8WXI7 | |
| STPGSAVQWAKDGLL | 56 | O60500 | |
| TLRAGESALELWGGP | 171 | O60496 | |
| ASARLTVLWAEGLPG | 411 | Q8IVU1 | |
| ALSAWEGPSTSRALG | 966 | Q9UJ55 | |
| EWLRALSGGGSVASP | 11 | O75420 | |
| AGWRALVEFLTPLGS | 106 | A6NH11 | |
| TLPQGFTWDALDLGD | 151 | P30419 | |
| ILWLSGAELGTLPAG | 231 | Q9Y4C4 | |
| RETLLPWSGLSEGTG | 506 | O43187 | |
| RAAGAVGTLLSWPSS | 86 | A5PLN7 | |
| TAPSLDDDGWATVGV | 796 | Q6UXM1 | |
| DGVLSEWSGRSPSSL | 816 | Q658Y4 | |
| LGNSSEGRTWDLPSA | 81 | Q9Y2U2 | |
| EGSKAVPWVILSDGD | 191 | Q8WVQ1 | |
| VSALWEGLPGNLDAA | 326 | Q99542 | |
| ALLLGAEPESWAAGA | 91 | Q13370 | |
| SVPWDDSLRGAVAGA | 1466 | P48681 | |
| WASGLETLDSLGGVL | 121 | P41159 | |
| NWPLLEEVAAGSLRG | 231 | P0C6S8 | |
| LEVSPGDTGWDVFSL | 626 | Q96CW5 | |
| GWLPQETLELSGSRL | 306 | Q96LB0 | |
| FLSAPLIGALSDVWG | 86 | Q96MC6 | |
| LSGVAGWRALTAPST | 156 | Q8N4S7 | |
| ELALLSTGVFIGWTP | 196 | Q9UGF6 | |
| PSLAQEELGWTAALG | 311 | Q14376 | |
| GPEWLRALSSGGSIT | 11 | Q6Y7W6 | |
| GPSWAKALEEAGTIL | 281 | Q9H8Y5 | |
| LAGPESLPSWALSDT | 221 | Q96C92 | |
| LSPISLAESWEDGSP | 236 | A1L170 | |
| FAGWSGVLDLILTPA | 296 | Q96SL1 | |
| QAGLELLGSSDSPTW | 261 | Q5JPI9 | |
| ILSWEYLSGGSSIPE | 171 | Q9Y5N1 | |
| SSLGAPVHLWGTEEV | 1136 | Q16760 | |
| GTLDPNTREWTDGLF | 2266 | Q14204 | |
| AALGVTWGLDASSPL | 21 | Q9NWW0 | |
| TASLWSGPGLEDRGL | 606 | Q13751 | |
| ADLNSDGWPDLIVGA | 371 | Q13683 | |
| LLWAGSALLAPETGD | 2261 | Q9NYQ7 | |
| GPLVVLLDVGASAWA | 111 | P13807 | |
| DAIPGKWTSQDSLLG | 1586 | P49327 | |
| LAKGSERSGLSEWLG | 431 | Q13183 | |
| ERSGLSEWLGNKLTP | 436 | Q13183 | |
| TPILGAAIADSWLGK | 96 | Q16348 | |
| RSVLLSWEPGSDGLS | 1416 | Q58EX2 | |
| LGALSGWAASDDPIE | 16 | Q6UWP8 | |
| IPVSGALLTDWSDDT | 46 | Q1ZYL8 | |
| GALSIWPLTQDLDSG | 286 | Q9P1A2 | |
| LWTELTGLAASSEPE | 51 | Q96AC6 | |
| SAPLIGALSDVWGRK | 96 | Q5VZR4 | |
| SAPLIGALSDVWGRK | 96 | Q5SR56 | |
| LRDTAPGTTLQWGAA | 286 | Q9C009 | |
| RSWTGQELSPLAGED | 1401 | O94851 | |
| PTAVTLGTGAAWLGV | 336 | O15547 | |
| GTTSLFLPGASWIAD | 2771 | Q6ZRI0 | |
| TSPSWGKGAELLLGD | 1006 | Q10571 | |
| GGWGLPSVDLDSLAV | 161 | Q13505 | |
| ELTWSGSPRAGQLDS | 921 | Q8NEY1 | |
| TLSWLPGDNGGSSIR | 1396 | O60469 | |
| NKWALLTDPGDIRTG | 181 | Q2WGJ9 | |
| IPAILIGAIGASTDW | 286 | Q9GZV3 | |
| GLWLALVDGLVRSSP | 31 | Q8N2H4 | |
| AGRAAAAVTWLLGEP | 61 | Q9H6L5 | |
| TRWGSPTSLEGELGA | 791 | Q6ZNJ1 | |
| LEVLAGSPGVESFWE | 971 | O14594 | |
| SLQAVPGAKDGTSLW | 1131 | P58107 | |
| TSAGWDGLLAPILNS | 1696 | Q15858 | |
| AVPVWSAGLELSAGT | 661 | Q8N196 | |
| AGEVTDLLPGLAWSS | 96 | A0A1B0GU29 | |
| IGLIASSWGGTPIEA | 211 | Q9HAT2 | |
| TLWGETALTAAAGRG | 1076 | Q9C0D5 | |
| ALFRELISWGAPGSA | 111 | Q03518 | |
| LISWGAPGSADSTRL | 116 | Q03518 | |
| NSGLLAGLWEFPSVT | 391 | Q9UIF7 | |
| LVGSISEPGLGLLSW | 186 | Q9Y535 | |
| TTSAGWDGLLAPILN | 1706 | Q9NY46 | |
| VATWLKSDVGLGESP | 496 | Q9NQW1 | |
| GRELWSESPLGDLVS | 446 | Q9BZV3 | |
| AGERSPSLEAPSLWE | 466 | E7EW31 | |
| GTPWALALLRTFDAG | 6 | P57078 | |
| GALWLLPALQEDSGT | 91 | P27930 | |
| TTSAGWDGLLAPILN | 1721 | P35498 | |
| GLPGWVLAVSATAAA | 26 | Q9C0B6 | |
| SALGKSPWLAGNELT | 261 | Q13155 | |
| QSTAAGLWALLGDPV | 76 | Q9UBY8 | |
| PGLQRSLGVWSLEAA | 46 | Q9NS84 | |
| LSSDPGGLESDTLQW | 116 | Q86T13 | |
| TWIEGLTGLSIGPDF | 36 | Q99439 | |
| DVWSSLRLPSGLGCS | 361 | P22234 | |
| NISALTDLGGLDPVW | 51 | Q96FV3 | |
| GLSRASAELWTPDSE | 201 | Q8WVN6 | |
| AWLSPKVLVSGAEDG | 1976 | Q99973 | |
| STGSRDLGAALADWP | 121 | Q9UNW1 | |
| WVLAGSESLPVETLG | 11 | Q96AQ6 | |
| EPIGSATDIWGAGVL | 3136 | Q15772 | |
| GPVYSTWSALEGELA | 281 | Q5VWJ9 | |
| LKPLLEAGTSGTWGS | 556 | P41226 | |
| TAVIGLPSGLESWSF | 41 | P35813 | |
| GGEASTLSIWDLAAP | 551 | Q04727 | |
| GERVSLLSPGWSALA | 101 | Q8N9U9 | |
| TTSAGWDGLLAPILN | 1711 | Q99250 | |
| WGTEPTSGLGIILDS | 421 | Q5SRE5 | |
| SGLRTDPLWELLVGS | 91 | C9JH25 | |
| DPLWELLVGSSGNSL | 96 | C9JH25 | |
| PAELVDSSGWATILA | 716 | O00534 | |
| EVTSEWAGSLDPISG | 676 | Q6ZSY5 | |
| ANSEPWTLDTLGGER | 1646 | O95359 | |
| WPDSGSIAGGTLLTL | 1161 | Q86WI1 | |
| LERTWGPAAGLEAQL | 46 | O14512 | |
| PSRWGLEDEETSSGL | 886 | Q8IUG5 | |
| ALLGPESDGFLAWST | 71 | Q9H6L2 | |
| ATAPAALEGGWESSL | 236 | A6NGB7 | |
| LSGSDWLGTIAAGDI | 711 | Q8WUA4 | |
| TPAVTLLLGDHGWVE | 186 | Q53H54 | |
| LLSGWLGSEDAAFVP | 36 | A0AVI4 | |
| STDDESNPLGRAGIW | 1376 | Q14669 | |
| GGEASTLSIWDLAAP | 521 | Q04725 | |
| GAPLDSVGSDVWSTE | 696 | Q5H9R7 | |
| PLTTDWRILSGKGSG | 21 | Q6ZTI0 | |
| EVVDPSGGWATLLES | 336 | Q9NQA3 | |
| PVDSKVLWVAGLSGT | 501 | Q12836 | |
| AGLLDLPDASVNGWS | 676 | Q13488 | |
| VSTGLESPGGLAVDW | 506 | O75096 | |
| VDTSLESPAGLAIDW | 811 | O75096 |